Approved Study Database

Ref. No. Scientific Title Principal investigator
2022.039 Impact of early sepsis care with the National Early Warning Score 2-guided Sepsis Hour-1 Bundle in the emergency department: a hybrid type 1 effectiveness-implementation pilot study (NEWS-1 Trial Pilot Study) Dr. HUNG Kevin Kei Ching
洪磯正
2025.431 Mental health trajectories and influencing factors among physical trauma patients in Hong Kong: a prospective longitudinal study Prof. HUNG Kevin Kei Ching
2025.684 Establishing a comprehensive clinical prediction rule for the diagnosis of acute heart failure in the emergency department Prof. HUNG Kevin Kei Ching
2026.029 Association of mild traumatic brain injury (mTBI) biomarkers and clinical outcomes in older patients presenting to the emergency department Prof. HUNG Kevin Kei Ching
2025.413 Identification of trauma-induced coagulopathy in severely injured patients using logistic regression based and machine learning models: An ambispective cohort study using a 10-year trauma registry in Hong Kong Prof. HUNG Kevin Kei Ching
2024.316 Characteristics of bicycle related injuries presented to a trauma centre in Hong Kong Prof. HUNG Kevin Kei Ching
2017.302 Comparison of diclofenac with tramadol, tizanidine or placebo in the treatment of acute low back pain: multi-centre randomised controlled trial Dr. HUNG Kevin Kei Ching
洪磯正
2016.596 Effects of transdiagnostic psychological intervention ‘Problem Management Plus’ on psychological outcomes six months after physical trauma in Hong Kong: randomised controlled trial Prof. HUNG Kevin Kei Ching
洪磯正
2026.549 Impact of the COVID-19 pandemic on out-of-hospital cardiac arrest in Hong Kong — a territory-wide retrospective study Prof. HUNG Kevin Kei Ching
2017.585 Trauma team activation and outcomes of geriatric trauma in Hong Kong: 10 year single centre cohort study Dr. HUNG Kevin Kei Ching
洪磯正
2008.360 Intra-Articular Low Molecular Weight Hyaluronic Acid Preparation (Hyalgan) for Pain and Functional Improvement for osteoarthritis of the Hand and Elbow - A Preliminary Comparative Study of Injections at 4-Weekly Intervals and Weekly Intervals Professor HUNG Leung Kim
2009.570 Scrutinizing the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for tendon injuries - a study on their effects on failed tendon healing Prof. HUNG Leung Kim
2013.287 A pilot study in using auricular acupuncture and TENS on acupoints in alleviating delirium, urinary retention and constipation in postoperative hip fracture patients Professor Hung Leung Kim
2012.233 Does nutritional status in elderly hip fracture surgical patients after their outcome? Prof. HUNG Leung Kim
2011.555 Effect of redox modulation on cell recruitment and survival in tendon healing Professor HUNG Leung Kim
2012.527 Pressure changes under the body for bed-ridden patients under different body positions Professor HUNG Leung Kim
2013.413 A Pilot Study of the Effectiveness of a Novel Herbal Bath for the Treatment of Acute Ankle Sprain Injury Prof. Hung Leung Kim
2014.092 Localized thermal therapy on Acupoints for the treatment of Frozen Shoulder Prof. HUNG Leung Kim
2013.370 A PILOT STUDY ON THE EFFECTIVENESS OF A NOVEL HERBAL PATCH FOR THE TREATMENT OF PLANTAR FASCIITIS HUNG Leung-kim
2014.069 A PILOT STUDY ON THE EFFECTIVENESS OF A NANO HERBAL PREPARATION FOR THE TREATMENT OF PLANTAR FASCIITIS Prof HUNG Leung-kim
2016.045 A new bone age model thumb ossification composite index (TOCI) to predict skeletal maturity and curve progression profile in idiopathic scoliosis: reliability and validation studies with clinical and radiological parameters. Dr. HUNG Lik Hang
洪力恒
2021.365 NTEC Breast Cancer Center Breast Cancer Survival and Treatment Outcome Registry Retrospective review from 2011 to 2021 Dr. HUNG Ray Ka Wai
2020.355 High Ki-67 proliferation index and lack of chemotherapy are associated with reduced overall survival in patients with triple negative breast cancer: a retrospective cohort in a major breast center in Hong Kong Dr. HUNG Ray Ka Wai
2020.348 Asian Breast Cancer Management during Global COVID-19 Pandemic (ABC-COVID Study) Dr. Hung Ray Ka Wai
洪家偉
2020.421 Dual Spectroscopic Assessment (DSA) on tumor margin of breast cancer during breast conserving surgery with Near infrared (NIR) and Raman spectroscopy: A novel intraoperative margin assessment device Dr. HUNG Ray Ka Wai
2018.497 Hong Kong Child and Adolescent Psychiatric Epidemiologic Survey: Age 6 to 17 Dr. HUNG Se Fong
熊思方
2017.184 The effectiveness of Frailty Unit on the clinical outcomes among frail elder people in HK acute hospital: A Quasi Experimental Study Ms. HUNG Shirley Yu Kan
熊裕勤
2008.477 An Exploratory Qualitative Study on the Families Ms. Hung Wan Yan
2018.136 The Current Knowledge and Acceptance of Same Stage Bilateral Knee Replacement Surgery in Hong Kong Population Dr. HUNG Yuk Wah
洪煜華
2025.129 Neural and cognitive mechanisms to resolve dyslexia: Longitudinal studies with validation Dr. HUO Shuting
2026.497 Testing the compensation account in mitigating dyslexia and predicting Chinese-English word reading profile: A longitudinal study from primary to secondary school years in Hong Kong Prof. Huo Shuting
2025.053 Unmet needs and hidden cost of family caregivers of community dwelling older adults with major mental disorders in Hong Kong Dr. HUO Zhaohua
Zhaohua Huo
2024.045 Unmet needs and hidden cost of informal caregivers of people with major mental disorders in the community in Hong Kong Dr. HUO Zhaohua
2026.076 Predictive Models for Overweight and Associated Health Risks in Hong Kong Population: A Machine Learning Approach Dr. HUO Zhaohua
Zhaohua Huo
2024.581 Caring experiences, burden and perceptions of family caregivers and economic costs among institutionalized elders with neurocognitive disorders in Hong Kong Dr. HUO Zhaohua
2026.054 Cost-Effectiveness Analysis of Novel Blood-Based Biomarkers and Anti-Amyloid Therapies for Early Alzheimer’s Disease in a Super-Aged Society Dr. HUO Zhaohua
Zhaohua Huo
2009.459 A randomized, open-label, controlled, exploratory trial to characterize the results of daily oral administration of telbivudine 600 mg and tenofovir disoproxil fumarate 300 mg in combination or telbivudine 600 mg or tenofovir disoproxil fumarate 300 mg monotherapy given over 12 weeks on the kinetics of hepatitis B virus DNA in adults with HBeAg positive compensated CHB Dr. Huui Aric Josun
2017.643 Risk factors for a loss of extension after anterior cruciate ligament reconstruction Miss IEONG Ho Ieng
2020.562 GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) – A Pilot Study Dr. IP Bonaventure
葉耀明
2021.358 Prevalence and Prognosis of Atrial Fibrillation Patients with Coexisting Intracranial Atherosclerotic Disease Prof. IP Bonaventure Y.M.
Bonaventure Yiu Ming IP
2021.386 Impact of COVID-19 Vaccines on Cerebrovascular Health – a community-based study Dr. IP Bonaventure Yiu Ming
2023.026 Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies – a pilot study Dr. IP Bonaventure Yiu Ming
葉耀明
2022.352 Prevalence and Etiologies of Intracranial Stenosis in Patients with Antiphospholipid Syndrome: a cross sectional study Dr. IP Bonaventure Yiu Ming
葉耀明
2023.295 A Real-life study of Anti-CGRP medication in Asian Patients with migraine (REAP) Dr. IP Bonaventure Yiu Ming
2022.333 Direct Oral Anticoagulant Levels in Chinese Patients with Atrial Fibrillation – A Real- World Pharmacokinetic Study (DOAC-REAL) Dr. IP Bonaventure Yiu Ming
葉耀明
2022.414 Effective Translation of Endovascular Thrombectomy Trials into Real-world Practice in the Asia-Pacific: a multicenter, prospective registry (ENDURE-APAC) Dr. IP Bonaventure Yiu Ming
葉耀明
2022.241 Brain Health in Oral Anticoagulant Recipients Dr. IP Bonaventure Yiu Ming
2022.194 Clinical outcome of Territory-wide Prehospital Stroke Notification in Hong Kong Dr. IP Bonaventure Yiu Ming
葉曜明
2023.340 Prognostication of Intracerebral hemorrhage – a population-based study Dr. IP Bonaventure Yiu Ming
2023.367 A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Dr. IP Bonaventure Yiu Ming

Page 110 of 289.